![Terence Rooney](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 4 M $ al 30/09/2026
Terence Rooney is currently Chief Medical Officer at Kymera Therapeutics, Inc. starting in 2026.
Formerly, Dr. Rooney was Medical Director-Rheumatoid Arthritis at Eli Lilly & Co. Education includes a doctorate from the Royal College of Surgeons.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 27/07/2026 | 38.000 ( 0,05 % ) | 4 M $ | 30/09/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| KYMERA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 27/07/2026 |
| Empresas | Cargo | Fin |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/02/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Royal College of Surgeons
 Royal College of Surgeons Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kymera Therapeutics, Inc.
 Kymera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops immunology medicines for health problems | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
